Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422433 · ClinicalTrials.gov registry record · NA
Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule
A NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT02422433: Active NA study of Barrett's Esophagus, sponsored by Massachusetts General Hospital.
NCT02422433 is a NA study of Barrett's Esophagus that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 130 participants, below the 518-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422433, a NA study of Barrett's Esophagus, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to test the feasibility, sensitivity, and specificity of the marking Optical Frequency Domain Imaging (OFDI) capsule for diagnosing Barrett's Esophagus (BE).
Primary Outcome
The images obtained by the OFDI capsule will be compared to the images obtained by the clinical endoscopy and histology.
Conditions Studied
Interventions
- DEVICE OFDI Capsule Marking
Study Locations (1)
Massachusetts
- Massachusetts General hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2014-06 |
| Est. Completion | 2029-12 |
| Phase | NA |
What the registry record for NCT02422433 still lists
NCT02422433 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Barrett's Esophagus appearing as the primary indexed condition, and to 1 intervention - of which OFDI Capsule Marking is the first listed.
NCT02422433 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02422433 about?
NCT02422433 is a clinical study titled "Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule". The purpose of this research is to test the feasibility, sensitivity, and specificity of the marking Optical Frequency Domain Imaging (OFDI) capsule for diagnosing Barrett's Esophagus (BE).
What is the current status of trial NCT02422433?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2014-06. Estimated completion is 2029-12.
What conditions does trial NCT02422433 study?
This clinical trial studies the following conditions: Barrett's Esophagus.
What interventions are being tested in trial NCT02422433?
The interventions under investigation include: OFDI Capsule Marking (DEVICE).
Who is sponsoring clinical trial NCT02422433?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422433 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02422433's enrollment target sits among peer trials
130 6th of 22 higher than 17 of 22 other Barrett's Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett's Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
-
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
COMPLETED · NA
-
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
COMPLETED · NA
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
COMPLETED · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia